Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study
Nicola Hermann, Lara Valeska Maul, Milad Ameri, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4576-4576
Open Access | Times Cited: 9

Showing 9 citing articles:

Vitiligo-like hypopigmentation secondary to adjuvant checkpoint inhibitor therapy in patients with resectable stage III melanoma: a cohort from two tertiary hospitals
Mónica Pozuelo‐Ruiz, Blanca de Unamuno‐Bustos, Rodolfo David Palacios‐Diaz, et al.
Melanoma Research (2025)
Closed Access
Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
Zhiyong Dong, M. He, Y. Hu
Dermatologic Therapy (2025) Vol. 2025, Iss. 1
Open Access
Impact of osteoprotective therapies on the efficacy of immune checkpoint inhibition in melanoma patients - a multicentre study from the prospective skin cancer registry ADOReg
Corinna Kochanek, Katrin Schaper‐Gerhardt, Lisa Zimmer, et al.
EJC Skin Cancer (2025), pp. 100731-100731
Open Access
Recent Progress in the Diagnosis and Treatment of Melanoma and Other Skin Cancers
Laura Pawlik, Sarah Morgenroth, Reinhard Dummer
Cancers (2023) Vol. 15, Iss. 6, pp. 1824-1824
Open Access | Times Cited: 7
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center
João Queirós Coelho, Raquel Romão, Maria João Sousa, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 1113-1128
Open Access | Times Cited: 2
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies
Christopher J. Fay, Samantha Jakuboski, Beth N. McLellan, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 5, pp. 765-785
Closed Access | Times Cited: 2
Immune checkpoint inhibitor-induced cutaneous toxicities: a review of histopathologic and clinical features
J Martel, Hannah L. Hanania, Anisha B. Patel
Human Pathology (2023) Vol. 140, pp. 144-172
Closed Access | Times Cited: 1
Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis
Lukas Kraehenbuehl, Stephanie Schneider, Laura Pawlik, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 935-935
Open Access | Times Cited: 1
[Advances in Predictive Research of Immune Checkpoint Inhibitors-related 
Adverse Events].
Jing Zhang, Xueqin Chen, Shenglin Ma
PubMed (2023) Vol. 26, Iss. 10, pp. 789-794
Closed Access
Page 1

Scroll to top